Inergetics Announces the Launch of its Private Label Channel and Executes ... - MarketWatch (press release)

Inergetics Announces the Launch of its Private Label Channel and Executes ... MarketWatch (press release) Inergetics has developed Surgex® sports nutrition formula to meet the nutritional needs of professional, Olympic and amateur elite athletes that experience post-workout symptoms such as fatigue, loss of lean muscle, oxidative stress, and reduced immune ... and more »

Unusual alliances enable movement - PhysOrg.com

Unusual alliances enable movement PhysOrg.com During development, neurons in the spinal cord reach out to muscle fibers to form a direct line of communication called the neuromuscular junction. Once complete, motor neurons send chemical messengers, called acetylcholine, via that junction so you ... and more »

Unusual alliances 'allow you to wiggle your fingers' - TruthDive

Unusual alliances 'allow you to wiggle your fingers' TruthDive During development, neurons in the spinal cord reach out to muscle fibres to form a direct line of communication called the neuromuscular junction. Once complete, motor neurons send chemical messengers, called acetylcholine, via that junction so you ... and more »

Fitness Industry Dream Team Gains Muscle Mass With Latest Venture - Wall Street Journal (blog)

Fitness Industry Dream Team Gains Muscle Mass With Latest Venture Wall Street Journal (blog) “We have eight clubs in the mid-Atlantic with many more in various stages of development – Onelife and Crunch brands,” said John Galiani. “By partnering with NeV we now have the ability to choose the best brand for each location. and more »

Results From Phase I Clinical Trials Demonstrate Positive Safety Data of AVI ... - MarketWatch (press release)

Results From Phase I Clinical Trials Demonstrate Positive Safety Data of AVI ... MarketWatch (press release) By leveraging its highly differentiated RNA-based technology platform, AVI has built a pipeline of potentially transformative therapeutic agents, including eteplirsen, which is in clinical development for the treatment of Duchenne muscular dystrophy, ... and more »